BeStock  

Castle Biosciences CSTL

US equityMarket cap rank #3147Diagnostics & Research
$32.86 −$0.55 (-1.63%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $32.86 0.00%
Open$32.76
Prev close$33.41
Day range$32.54 – $33.38
Volume309.2K
Market cap$1.01B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$102.89M+23.9% YoY
Operating profit-$2.73M+59.9% YoY
Net profit-$4.10M-718.4% YoY
Diluted EPS-$0.13-550.0% YoY
Free cash flow$12.25M+57.1% YoY
Operating cash flow$19.74M

Revenue, last 8 quarters

$86.3MDec '24$88.0MMar '25$86.2MJun '25$83.0MSep '25$87.0MDec '25$83.7MMar '26$103.5MJun '26$102.9MSep '26

Net profit, last 8 quarters

$9.6MDec '24$-25.8MMar '25$4.5MJun '25$-501.0KSep '25$-2.3MDec '25$-14.5MMar '26$-2.1MJun '26$-4.1MSep '26

Diluted EPS by quarter

0.32Dec '24-0.90Mar '250.15Jun '25-0.02Sep '25-0.08Dec '25-0.49Mar '26-0.07Jun '26-0.13Sep '26

Free cash flow by quarter

$16.8MDec '24$-10.8MMar '25$11.6MJun '25$7.8MSep '25$19.7MDec '25$-34.6MMar '26$6.6MJun '26$12.2MSep '26

Annual revenue

$62.6MFY20$94.1MFY21$137.0MFY22$219.8MFY23$332.1MFY24$344.2MFY25

Profitability & balance sheet

Gross margin77.1%
Operating margin-7.4%
Net margin-6.1%
Return on equity-4.9%
Return on assets-4.0%
Return on invested capital-5.7%
Current ratio5.28
Liabilities / assets17.4%
Cash & investments$277.67M
Total debt$34.93M
Net cash (debt)$242.74M
Free cash flow / sales1.1%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $102.89M $103.55M $83.68M $344.23M $87.01M
Total Operating Revenue $102.89M $103.55M $83.68M $344.23M $87.01M
Cost of Revenue $23.92M $23.70M $20.53M $71.03M $18.32M
Gross Profit $78.97M $79.85M $63.15M $273.20M $68.70M
Operating Expense $81.70M $82.92M $81.55M $316.01M $72.52M
Selling and Admin Expenses $63.23M $66.12M $64.90M $229.32M $58.07M
-Selling & Marketing Expense $37.68M $40.92M $41.04M $138.12M $33.40M
-General & Admin Expense $25.56M $25.21M $23.86M $91.21M $24.67M
Research & Development $15.81M $14.54M $14.43M $51.85M $13.52M
Depreciation & Amortization & Depletion $2.66M $2.25M $2.23M $34.84M $939,000.00
-Depreciation & Amortization $2.66M $2.25M $2.23M $34.84M $939,000.00
Operating Profit -$2.73M -$3.07M -$18.41M -$42.81M -$3.83M
Net Non-Operating Interest Income (Expense) $2.32M $2.16M $2.41M $11.69M $2.87M
Non-Operating Interest Income $2.51M $2.36M $2.55M $11.77M $2.90M
Non-Operating Interest Expense $197,000.00 $193,000.00 $134,000.00 $86,000.00 $24,000.00
Other Income (Expense) -$3.39M -$783,000.00 $1.58M $1.61M -$1.76M
Gain on Sale of Security -$3.43M -$630,000.00 $2.02M $1.47M -$1.86M
Other Non-Operating Income (Expenses) $39,000.00 -$153,000.00 -$439,000.00 $144,000.00 $96,000.00
Pretax Profit -$3.80M -$1.69M -$14.41M -$29.51M -$2.71M
Tax $298,000.00 $370,000.00 $109,000.00 -$5.36M -$382,000.00
Net Profit -$4.10M -$2.06M -$14.52M -$24.16M -$2.33M
Profit from Continuing Operations -$4.10M -$2.06M -$14.52M -$24.16M -$2.33M
Net Income to Parent Company -$4.10M -$2.06M -$14.52M -$24.16M -$2.33M
Net Income to Common Stockholders -$4.10M -$2.06M -$14.52M -$24.16M -$2.33M
Basic EPS -$0.13 -$0.07 -$0.49 -$0.83 -$0.08
Diluted EPS -$0.13 -$0.07 -$0.49 -$0.83 -$0.08

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $579.41M $561.18M $547.81M $578.56M $578.56M
Total Current Assets $356.86M $341.10M $328.90M $361.10M $361.10M
Cash and Cash Equivalents & Short-Term Investments $277.67M $266.81M $261.69M $299.51M $299.51M
-Cash and Cash Equivalents $77.99M $62.12M $63.76M $116.73M $116.73M
-Short Term Investments $199.67M $204.69M $197.92M $182.78M $182.78M
Receivables $52.10M $48.34M $42.26M $43.38M $43.38M
-Accounts Receivable $52.10M $48.34M $42.26M $43.38M $43.38M
Inventory $10.38M $10.58M $10.46M $10.25M $10.25M
Other Current Assets $16.71M $15.37M $14.49M $7.96M $7.96M
Total Non-Current Assets $222.55M $220.08M $218.90M $217.46M $217.46M
Net PPE $125.43M $118.88M $115.36M $112.24M $112.24M
-Gross PPE $149.11M $140.52M $135.22M $130.54M $130.54M
-Accumulated Depreciation -$23.68M -$21.64M -$19.86M -$18.30M -$18.30M
Non Current Accounts Receivables $1.26M $1.66M $1.92M $1.88M $1.88M
Goodwill and Other Intangible Assets $91.49M $95.10M $97.35M $99.57M $99.57M
-Goodwill $10.69M $10.70M $10.70M $10.69M $10.69M
-Other Intangible Assets $80.80M $84.40M $86.65M $88.88M $88.88M
Other Non-Current Assets $4.36M $4.44M $4.28M $3.77M $3.77M
Total Liabilities $100.96M $91.15M $86.39M $107.68M $107.68M
Total Current Liabilities $67.61M $56.51M $48.76M $68.68M $68.68M
Payables $19.07M $14.26M $15.04M $18.71M $18.71M
-Accounts Payable $13.23M $9.67M $15.04M $18.71M $18.71M
-Total Tax Payable $5.84M $4.59M – – –
Current Accrued Expenses $6.69M $6.39M $6.73M $5.89M $5.89M
Short-Term Debt and Capital Lease Obligation $5.81M $4.33M $2.92M $1.74M $1.74M
-Current Debt $4.17M $2.92M $1.67M $417,000.00 $417,000.00
-Current Capital Lease Obligation $1.64M $1.42M $1.25M $1.33M $1.33M
Other Current Liabilities $2.12M $3.50M $4.67M $3.13M $3.13M
Total Non-Current Liabilities $33.35M $34.64M $37.63M $39.01M $39.01M
Long Term Debt and Capital Lease Obligation $30.76M $32.32M $33.80M $35.17M $35.17M
-Long Term Debt $5.92M $7.16M $8.40M $9.64M $9.64M
-Long Term Capital Lease Obligation $24.85M $25.16M $25.40M $25.53M $25.53M
Non-Current Deferred Liabilities $2.40M $2.32M $2.33M $2.34M $2.34M
Other Non-Current Liabilities $191,000.00 – $1.50M $1.50M $1.50M
Total Equity $478.44M $470.03M $461.42M $470.87M $470.87M
Stockholders' Equity $478.44M $470.03M $461.42M $470.87M $470.87M
Capital Stock $31,000.00 $31,000.00 $30,000.00 $30,000.00 $30,000.00
-Common Stock $31,000.00 $31,000.00 $30,000.00 $30,000.00 $30,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $723.87M $711.12M $700.26M $694.86M $694.86M
Retained Earnings -$244.97M -$240.87M -$238.81M -$224.28M -$224.28M
Gains/Losses Not Affecting Retained Earnings -$492,000.00 -$256,000.00 -$63,000.00 $267,000.00 $267,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $19.74M $15.20M -$22.13M $64.35M $26.93M
Net cash flow from continuing operations $19.74M $15.20M -$22.13M $64.35M $26.93M
Net Income from Continuing Operations -$4.10M -$2.06M -$14.52M -$24.16M -$2.33M
Depreciation & Depletion & Amortization $4.18M $4.07M $3.93M $40.77M $3.78M
Deferred Tax $76,000.00 -$3,000.00 -$10,000.00 -$6.23M -$907,000.00
Other Non-Cash Items $139,000.00 $235,000.00 $532,000.00 $153,000.00 -$129,000.00
Change in Working Capital $5.13M $1.13M -$19.36M $13.60M $13.97M
-Change in Receivables -$3.36M -$5.82M $1.08M $6.88M $6.27M
-Change in Inventory $199,000.00 -$119,000.00 -$207,000.00 -$2.14M -$1.60M
-Change in Prepaid Assets -$1.29M -$877,000.00 -$6.67M -$544,000.00 $3.99M
-Change in Payables and Accrued Expense $9.21M $8.03M -$13.23M $9.68M $5.48M
-Change in Other Current Assets $294,000.00 -$30,000.00 -$159,000.00 $1.01M $44,000.00
-Change in Other Current Liabilities $85,000.00 -$59,000.00 -$172,000.00 -$1.28M -$209,000.00
Net cash flow from investing -$4.73M -$15.96M -$25.80M -$60.37M $8.83M
Net Cash Flow from Continuing Investing Activities -$4.73M -$15.96M -$25.80M -$60.37M $8.83M
Net PPE Purchase and Sale -$7.48M -$8.64M -$12.45M -$35.98M -$7.18M
Net Investment Purchase and Sale $2.76M -$7.32M -$13.36M $2.02M $23.69M
Financing Cash Flow $866,000.00 -$886,000.00 -$5.03M -$6.96M -$4.59M
Net Cash Flow from Continuing Financing Activities $866,000.00 -$886,000.00 -$5.03M -$6.96M -$4.59M
Net Issuance Payments Of Debt -$26,000.00 -$24,000.00 -$24,000.00 $75,000.00 -$27,000.00
Proceeds from Stock Option Exercised $1.82M $931,000.00 $1.59M $4.62M $2.81M
Net Other Financing Charges -$923,000.00 -$1.79M -$6.60M -$11.66M -$7.37M
Ending Cash Balance $77.99M $62.12M $63.76M $116.73M $116.73M
Net Change in Cash $15.88M -$1.65M -$52.97M -$2.98M $31.17M
Beginning Cash Balance $62.12M $63.76M $116.73M $119.71M $85.56M
Free Cash Flow $12.25M $6.55M -$34.58M $28.33M $19.75M
Gain/Loss from Continuing Operations – – -$2.02M -$1.47M –
Net Business Purchase and Sale – – – -$18.73M –
Net Other Investing Changes – – – -$7.68M $11.04M

Discussion

No comments yet — be the first to weigh in on CSTL.

Sign in to join the discussion.

Scroll to Top